Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Current Deferred Revenue (2017 - 2020)

enVVeno Medical has reported Current Deferred Revenue over the past 4 years, most recently at $33000.0 for Q4 2020.

  • For Q4 2020, Current Deferred Revenue changed 0.0% year-over-year to $33000.0; the TTM value through Dec 2020 reached $33000.0, changed 0.0%, while the annual FY2020 figure was $33000.0, 0.0% changed from the prior year.
  • Current Deferred Revenue for Q4 2020 was $33000.0 at enVVeno Medical, roughly flat from $33000.0 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $103400.0 in Q4 2017 and troughed at $33000.0 in Q4 2018.
  • A 4-year average of $40400.0 and a median of $33000.0 in 2018 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: crashed 68.09% in 2018 and later changed 0.0% in 2019.
  • Year by year, Current Deferred Revenue stood at $103400.0 in 2017, then crashed by 68.09% to $33000.0 in 2018, then changed by 0.0% to $33000.0 in 2019, then changed by 0.0% to $33000.0 in 2020.
  • Business Quant data shows Current Deferred Revenue for NVNO at $33000.0 in Q4 2020, $33000.0 in Q3 2020, and $33000.0 in Q2 2020.